Projektbeschreibung
Personalisierte Überwachung des Vitamin-B6-Spiegels
Vitamin B6 spielt für den menschlichen Organismus eine entscheidende Rolle. Ein Mangel kann zu schweren gesundheitlichen Problemen führen. Bei älteren Menschen sowie Menschen mit Alkoholproblemen und Diabetes besteht tatsächlich ein Zusammenhang zwischen B6-Mangel und Herz-Kreislauf-Erkrankungen, Krebs und Schlaganfall. Bestehende Überwachungssysteme des Vitamin-B6-Spiegels sind langsam und unzuverlässig. Zudem kann diese Arbeit nur von einem Arzt oder einer Ärztin oder in einem Labor durchgeführt werden, was die Kosten sowie die Diagnosezeit in die Höhe treibt. Das EU-finanzierte Projekt B6VitaStat präsentiert ein benutzerfreundliches Gerät mit kosteneffizienter und zuverlässiger Technik, die den Vitamin-B6-Spiegel bei Risikopatientinnen und -patienten kontinuierlich überwacht. Das innovative Gerät bietet eine personalisierte Diagnose des B6-Spiegels und ist überall einsetzbar, auch in weniger entwickelten Ländern.
Ziel
Vitamin B6 is an essential nutrient and part of a well-balanced diet. However, B6 deficiency is often observed in elderly people, diabetes patients and alcoholics and associated with higher rates of cardiovascular disease, stroke and cancer. All these risk populations need a stringent and continuous monitoring of B6 levels. At present B6 detection systems suffer from limited speed, scope, convenience and reliability. These tests require a medical doctor as well as external laboratories with expensive and specialized equipment for analysis increasing the overall costs. We here develop a customized assay for vitamin B6 detection with a desired application as reliable, cheap and easy-to-use point-of-care device. This assay system, termed B6VitaStat, is based on the direct monitoring of cofactor binding into diverse enzyme active sites which will be performed in erythrocytes drawn from blood. Key to B6VitaStat is a tailored probe which mimics the structure of the cofactor. This probe is equipped with a recognition tag allowing to visualize binding to B6-dependent enzymes. The less B6 is bound, the stronger the signal, the higher the overall deficiency. This principle will be incorporated in an easy-to-use device that is based on an antibody printed microarray hallmarked by its cheap and reproducible production. The robust array can be used world-wide including developing countries with less pronounced medical infrastructure. The B6VitaStat team combines complementary expertise including chemistry, engineering and entrepreneurship, which will provide a basis for the envisioned commercialization. Given that B6VitaStat will be the first device of this class we estimate a significant cost reduction compared to current clinical procedures. Overall, we aim to introduce a new device for constant monitoring B6 vitamin status in risk patients and provide a cheap, easy-to-use and reliable method suited for all kinds of applications including those in less-developed countries.
Wissenschaftliches Gebiet
- medical and health sciencesclinical medicineendocrinologydiabetes
- medical and health scienceshealth sciencesnutrition
- medical and health sciencesclinical medicinecardiologycardiovascular diseases
- medical and health sciencesbasic medicineneurologystroke
- natural sciencesbiological sciencesbiochemistrybiomoleculesproteinsenzymes
Programm/Programme
Thema/Themen
Finanzierungsplan
ERC-POC-LS - ERC Proof of Concept Lump Sum PilotGastgebende Einrichtung
80333 Muenchen
Deutschland